APA (7th ed.) Citation

JA, H., WB, L., JF, C., CJ, L., & EP, S. (2020). Heparin as a therapy for COVID-19: Current evidence and future possibilities. American journal of physiology. Lung cellular and molecular physiology, 319(2), L211. https://doi.org/10.1152/ajplung.00199.2020

Chicago Style (17th ed.) Citation

JA, Hippensteel, LaRiviere WB, Colbert JF, Langouët-Astrié CJ, and Schmidt EP. "Heparin as a Therapy for COVID-19: Current Evidence and Future Possibilities." American Journal of Physiology. Lung Cellular and Molecular Physiology 319, no. 2 (2020): L211. https://doi.org/10.1152/ajplung.00199.2020.

MLA (9th ed.) Citation

JA, Hippensteel, et al. "Heparin as a Therapy for COVID-19: Current Evidence and Future Possibilities." American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 319, no. 2, 2020, p. L211, https://doi.org/10.1152/ajplung.00199.2020.

Warning: These citations may not always be 100% accurate.